They reported that anti-sLx CSLEX and KM93 mAbs did not block adhesion, probably because of the very low levels of sLx expression in the cancer cell lines detected by Western blotting, and that the anti-sLa CA19-9 mAb blocked adhesion of one cancer cell line but not that of another cancer cell line. The gene discussed is SLA; the disease is cancer.